Dr. Patil’s biostatistical research interests are in longitudinal data analysis, survival analysis, clinical trial design, analysis of incomplete data, measurement error models, and Bayesian methods. Dr. Patil uses these methods routinely in her clinical collaborations with oncologists and surgeons in the Genitourinary, Breast, and Colorectal Surgery Services, where she serves as the primary faculty statistician. Dr. Patil’s current methodologic work is in two areas: developing approaches to compare cumulative risk distributions of two events; and how to design studies where there are competing events. In completed work, she has examined stage migration in metastatic renal cell carcinoma over the last four decades in internal and external datasets. Dr. Patil serves as a faculty lecturer for the Department of Surgery Clinical Research Methods Lecture Series and for the K30 Clinical Trial Symposium. With her colleague Dr. Satagopan, she is coordinator of a biostatistics course targeted to biomedical scientists at the Sloan Kettering Institute. She also serves on Research Council, MSK’s scientific review committee for all human subjects’ studies.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Sujata Patil discloses the following relationships and financial interests:
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2019 through disclosure submission in spring 2020). This data reflects interests that may or may not still exist. This data is updated annually.
View all disclosures